Medical Cannabis Advocacy in Sub-Saharan Africa During the 1970s

How traditional use was conflated with organized advocacy in retrospective cannabis histories.

Sourced and fact-checked
6 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

Traditional medicinal cannabis use in Sub-Saharan Africa is ancient and well-documented. But 'traditional use' and 'organized advocacy for legal medical access' are different things. The 1970s saw neither government medical programs nor civil-society campaigns for legal medical cannabis in the region. Modern histories sometimes conflate all three, projecting a longer advocacy lineage backward that the primary sources don't support.

By 1970, cannabis—known regionally as dagga, bhang, matekwane, njemu, and dozens of other names—was prohibited across most of Sub-Saharan Africa. Colonial-era prohibition laws, many dating to the 1920s, had been retained or hardened by post-independence governments. South Africa's Abuse of Dependence-Producing Substances and Rehabilitation Centres Act of 1971 replaced earlier legislation and imposed severe penalties for possession and dealing [1]. The 1961 Single Convention on Narcotic Drugs, which classified cannabis in Schedule IV alongside heroin, had been ratified by numerous African states through the 1960s and 1970s and structured domestic policy [2] Strong evidence.

This context is essential: the 1970s were a decade of prohibition consolidation, not reform. Any framing that portrays the era as one of active medical cannabis advocacy in the region misreads the primary historical record.

Traditional Medicinal Use vs. Organized Advocacy

Traditional medicinal use of cannabis in Sub-Saharan Africa is old, well-documented, and continued through the 1970s regardless of legal status. Brian du Toit's ethnographic work, culminating in Cannabis in Africa (1980), documented use across South Africa, Lesotho, Swaziland, and neighboring states for conditions including asthma, snakebite, malaria symptoms, and childbirth pain [3] Strong evidence. Sula Benet's comparative work also noted African medicinal traditions in her analysis of early hemp diffusion [4] Strong evidence.

But traditional use is not the same as advocacy. No evidence appears in the accessible primary record—legislation, government commissions, medical journals, or newspapers of record from the 1970s—of organized African civil-society campaigns pushing for legal medical cannabis access No data. Rastafarian communities in Southern and Eastern Africa, as well as the Caribbean, argued for sacramental and healing use on religious grounds Weak / limited, but this represented religious-liberty framing rather than medical-regulatory advocacy or public health campaigns.

Academic Pharmacology and Clinical Work

The clearest 1970s scholarly engagement with cannabis in Sub-Saharan Africa came from pharmacologists and psychiatrists, not activists or medical reformers. Frances Ames, a South African psychiatrist at the University of Cape Town, published clinical observations on cannabis psychosis in 1958 and continued research into the 1970s [5] Strong evidence. Her work was clinical description—documenting adverse effects—rather than pro-legalization advocacy.

University of Cape Town and University of the Witwatersrand pharmacology departments engaged sporadically with cannabis chemistry during the decade, but Sub-Saharan African cannabis research in the 1970s was dwarfed by output from Israel (Raphael Mechoulam's group), the United States, and the United Kingdom Weak / limited. No African medical society issued a policy position calling for legal medical cannabis access during the 1970s in the surviving record. The absence of such statements, combined with the regional adherence to the 1961 Single Convention, reflects the decade's policy consensus.

A few moments are sometimes retrospectively cited as evidence of "medical advocacy," though they fit that label loosely:

South African legislative action: The Grobler Commission (1952) and subsequent policy reviews preceded the 1970s and did not recommend medical liberalization. The 1971 Act tightened, rather than loosened, restrictions [1] Strong evidence.

Rastafarian legal defenses: Throughout the 1970s in South Africa and later in Zimbabwe and other states, Rastafarian defendants raised religious-freedom defenses in possession cases. These were almost uniformly unsuccessful during the decade Weak / limited.

Traditional healer organizations: Some traditional healers' associations, particularly in Southern Africa, quietly maintained that cannabis was part of their pharmacopoeia. This was descriptive practice rather than public health or medical advocacy Anecdote.

No African government during the 1970s created a medical cannabis access program. The first meaningful African medical cannabis regulatory frameworks did not emerge until Lesotho (2017), Zimbabwe (2018), and South Africa (following the 2018 Constitutional Court private-use judgment) [6] Strong evidence.

How the Myth Developed

Popular cannabis histories—particularly online—sometimes imply a robust African medical cannabis tradition that was formally "advocated for" in the 1970s. This conflates three distinct things:

  1. Deep traditional medicinal use (real, well-documented, continuous across the region).
  2. Ethnobotanical and anthropological scholarship documenting that use (real, but academic in nature, not activist).
  3. Organized political advocacy for legal medical access (essentially absent in Sub-Saharan Africa during the 1970s).

The conflation is retrospective. As post-2010 African cannabis reform accelerated, some commentators projected a longer advocacy lineage backward. The primary sources—legislation, medical journals, newspapers of record from the period—do not support that projection No data.

The honest history is that Sub-Saharan Africa entered the 1970s with widespread traditional cannabis use under prohibition and exited the 1970s with that same pattern intact. Meaningful medical advocacy in the region is largely a 21st-century development, drawing on both traditional-use arguments and the international medical cannabis evidence base built elsewhere.

Research Limitations and What Remains Unknown

Archival research on 1970s African drug policy is limited compared to scholarship on Anglo-American and European cannabis regulation. Local-language newspapers, unpublished dissertations, government memos, and NGO records from Sub-Saharan Africa during the 1970s remain underexamined in the English-language historiography. It is possible that such sources contain evidence of small-scale advocacy or policy discussions that have not yet entered accessible scholarship No data.

What is defensible from currently available sources is a negative claim: no substantial organized medical cannabis advocacy movement in Sub-Saharan Africa in the 1970s appears in the accessible record. If archival research reveals new evidence—particularly from regional-language sources or newly digitized government archives—this article should be updated to reflect it. Until such evidence surfaces, historians and cannabis policy scholars should resist the temptation to project backward from contemporary African cannabis reform movements.

Sources

How this page was made

Generation history

Jul 8, 2026
Fact-check pass — raised 6 flags
Oct 31, 2026
Revision
Jul 9, 2026
Fact-check pass — raised 2 flags
Jul 9, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.